scholarly journals Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry

Author(s):  
Robert J. Gil ◽  
Adam Kern ◽  
Tomasz Pawłowski ◽  
Jacek Bil
2008 ◽  
Vol 121 (6) ◽  
pp. 492-497 ◽  
Author(s):  
Bo XU ◽  
Qi ZHANG ◽  
Yue-jin YANG ◽  
Shu-bin QIAO ◽  
Rui-yan ZHANG ◽  
...  

2020 ◽  
Vol 16 (5) ◽  
pp. 397-404
Author(s):  
Dobrin Iotkov Vassilev ◽  
Niya Boykova Mileva ◽  
Robert J Gill

The bifurcation optimization stent system (BiOSS) LIM (Balton, Warsaw, Poland) stent is a dedicated coronary bifurcation stent. Its unique construction is developed in accordance with the anatomy of the coronary bifurcations, thus eliminating the carina displacement as a mechanism of side branch ostium compromise. Since its development in 2008, the BiOSS stent underwent several changes with the latest version created of sirolimus eluting cobalt-chromium stent. Results from registries and randomized clinical trials showed that implantation of the BiOSS stent is safe and effective with comparable results for major adverse cardiovascular events (MACE) and target lesion revascularisation rates between the BiOSS and regular drug-eluting stent groups. This stent provides alternative for coronary bifurcation treatment, especially when there is a large difference in diameter between the main vessel and the main branch.


2013 ◽  
Vol 9 (5) ◽  
pp. 573-581 ◽  
Author(s):  
Ian Buysschaert ◽  
Christophe L. Dubois ◽  
Joseph Dens ◽  
John Ormiston ◽  
Stephen Worthley ◽  
...  

Joints ◽  
2017 ◽  
Vol 05 (04) ◽  
pp. 224-228 ◽  
Author(s):  
G. Solarino ◽  
C. Piconi ◽  
V. De Santis ◽  
A. Piazzolla ◽  
B. Moretti

AbstractTotal knee arthroplasty (TKA) is a well-established surgical procedure in the late stages of knee osteoarthritis. Nevertheless, this procedure is associated with a percentage of unsatisfactory results and biomechanical failures, with aseptic loosening being the most common cause of revision. Beside these problems, cutaneous and systemic hypersensitivity reactions to metals have arisen as an increasing concern after joint arthroplasties, even if allergies against implant materials are still a quite rare and not well-known problem. Ceramic composites have been recently used in prosthetic components, showing minimum wear and excellent long-term results in total hip replacement, due to their high resistance to scratching and their better wettability with respect to cobalt–chromium alloy. Furthermore, the biologic response to debris generated from these bearings is less aggressive. Knee joint simulator tests and clinical results demonstrate promising results of TKAs with ceramic components that should led to benefit for the patients.


2005 ◽  
Vol 284-286 ◽  
pp. 1003-1006
Author(s):  
Clifford W. Colwell ◽  
J.A. D'Antonio ◽  
W.N. Capello ◽  
M.E. Hardwick

Alumina ceramic is an excellent material for biologic implantation. Decreased particulate wear debris should increase implant longevity. The purpose of this study is to examine clinical and radiological results of ceramic-on-ceramic hip implants compared to cobalt chrome on polyethylene. Four cementless systems were compared, three alumina-on-alumina bearing systems: System I, porous coated cup; System II, hydroxyapatite-coated cup; Trident system, hydroxyapatite-coated cup with metal sleeve backing on ceramic cup liner; and System III (control), porous-coated cup with polyethylene and cobalt chromium bearing system. Patients were randomized to receive System I, II, or III. Trident patients were not randomized. Examinations are performed at 6 months, 1 year and yearly thereafter including x-rays, clinical exam and Harris Hip Score (HHS). Minimum 24-month followup was performed in 562 ceramic hips and 154 control hips. Age, height, weight, gender and diagnosis were similar in all groups. HHS was rated good/excellent by 95 percent of ceramic hips and 97 percent of control hips. Radiographic results demonstrated radiolucency in Femoral Gruen Zone 1 in 3.8 percent (18/474) of ceramic hips and in 8 percent (10/128) of control hips. Unstable acetabular components were reported in none of ceramic hips and in 3.2 percent (5/154) of control hips. Revision was performed in 7 (1.2 percent) ceramic hips, none due to failure of ceramic materials, and in 9 (5.8 percent) control hips. Alumina ceramic materials show promise, but continued evaluation of long-term clinical results is needed.


2017 ◽  
Vol 14 (4) ◽  
pp. 279-284 ◽  
Author(s):  
Robert J. Gil ◽  
Jacek Bil ◽  
Mateusz Kaczynski ◽  
Krzysztof P. Milewski

1950 ◽  
Vol 14 (2) ◽  
pp. 214-227 ◽  
Author(s):  
Vernon A. Weinstein ◽  
Franklin Hollander ◽  
Frances U. Lauber ◽  
Ralph Colp

Sign in / Sign up

Export Citation Format

Share Document